Orchestra BioMed and Medtronic (NYSE: MDT) have a strategic collaboration to develop and commercialize AVIM Therapy for the treatment of uncontrolled hypertension in patients indicated for a pacemaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback